From 9 October 2015 to 4 May 2020 Richard Sharp was a director of medical research company Oncimmune Holdings Ltd. As at 31 October 2022 Sharp is the second largest shareholder of Oncimmune, via a blind trust.
Just prior to leaving Oncimmune in 2020 Sharp became an adviser to Chancellor Rishi Sunak
In October 2020 it was announced that Oncimmune would received government funding
This contract has a value of £500,000
